(Q36279221)

13 August 2017

1 reference

title

Chemotherapy-induced myelosuppression (English)

1 reference

13 August 2017

1 reference

M. B. Maxwell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1621002

16 October 2022

K. E. Maher

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1621002

16 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1621002

16 October 2022

publication date

1 May 1992

1 reference

full work available at URL

13 August 2017

https://api.elsevier.com/content/article/PII:074920819290027Z?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0749-2081(92)90027-Z

https://api.elsevier.com/content/article/PII:074920819290027Z?httpAccept=text/plain

16 October 2022

1 reference

https://api.crossref.org/works/10.1016/0749-2081(92)90027-Z

Seminars in Oncology Nursing

16 October 2022

published in

1 reference

13 August 2017

volume

8

1 reference

13 August 2017

issue

2

1 reference

13 August 2017

page(s)

113-123

1 reference

Physiology of blood and bone marrow

13 August 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0749-2081(92)90027-Z

Physiology of normal bone marrow

16 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0749-2081(92)90027-Z

Hematopoiesis: an overview

16 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0749-2081(92)90027-Z

Management of myelosuppression in the patient with cancer

16 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0749-2081(92)90027-Z

The human hematopoietic colony-stimulating factors

16 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0749-2081(92)90027-Z

The colony stimulating factors. Discovery, development, and clinical applications

16 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0749-2081(92)90027-Z

Hematologic complications of cancer chemotherapy

16 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0749-2081(92)90027-Z

Principles and practices of cancer chemotherapy

16 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0749-2081(92)90027-Z

Red blood cell transfusions for anemia

16 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0749-2081(92)90027-Z

Kinetics of human hemopoietic cells after in vivo administration of granulocyte-macrophage colony-stimulating factor

16 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0749-2081(92)90027-Z

Recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy: a phase Ib trial

16 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0749-2081(92)90027-Z

Hematopoietic responses in patients with advanced malignancy treated with recombinant human granulocyte-macrophage colony-stimulating factor

16 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0749-2081(92)90027-Z

Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow Transplantation

16 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0749-2081(92)90027-Z

Future strategies in the control of myelosuppression: the use of colony-stimulating factors

16 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0749-2081(92)90027-Z

A teaching booklet for patients receiving GM-CSF therapy

16 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0749-2081(92)90027-Z

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

16 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0749-2081(92)90027-Z

Hemopoietins in oncology: factoring out myelosuppression

16 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0749-2081(92)90027-Z

Recombinant human GM-CSF in myelosuppression of chemotherapy (continued)

16 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0749-2081(92)90027-Z

Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer

16 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0749-2081(92)90027-Z

The clinical use of hematopoietic growth factors

16 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0749-2081(92)90027-Z

16 October 2022

Identifiers

1 reference

release_smesja4zazdgdoxgjyscrcox6m

13 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/smesja4zazdgdoxgjyscrcox6m

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference